MIMEDX to Sponsor and Attend Symposium on Advanced Wound Care (SAWC) Fall
MIMEDX (NASDAQ:MDXG) has announced its participation in the Symposium on Advanced Wound Care (SAWC) Fall meeting from September 3-6, 2025 in Las Vegas. The company will host a sponsored lunch symposium titled "Change is Inevitable: Mastering the Art of Wound Healing in an Evolving Landscape" on September 4, 2025.
MIMEDX will showcase its advanced wound care portfolio at booth 511 and present six clinical and scientific posters focusing on various aspects of amniotic tissue applications, including pigment restoration, wound healing mechanisms, and cost-effectiveness analysis of placental allografts.
MIMEDX (NASDAQ:MDXG) ha annunciato la sua partecipazione al Symposium on Advanced Wound Care (SAWC) Fall, che si terrà dal 3 al 6 settembre 2025 a Las Vegas. L'azienda organizzerà un pranzo-simposio sponsorizzato intitolato "Change is Inevitable: Mastering the Art of Wound Healing in an Evolving Landscape" il 4 settembre 2025.
MIMEDX presenterà il suo portafoglio di prodotti per la cura avanzata delle ferite presso lo stand 511 e mostrerà sei poster clinici e scientifici che approfondiscono diversi aspetti delle applicazioni di tessuto amniotico, inclusi il ripristino della pigmentazione, i meccanismi di guarigione delle ferite e l'analisi costo-efficacia degli alloinnesti placentari.
MIMEDX (NASDAQ:MDXG) ha anunciado su participación en el Symposium on Advanced Wound Care (SAWC) Fall, que se celebrará del 3 al 6 de septiembre de 2025 en Las Vegas. La compañía organizará un simposio-almuerzo patrocinado titulado "Change is Inevitable: Mastering the Art of Wound Healing in an Evolving Landscape" el 4 de septiembre de 2025.
MIMEDX exhibirá su cartera de cuidados avanzados de heridas en el stand 511 y presentará seis pósteres clínicos y científicos centrados en varios aspectos de las aplicaciones de tejido amniótico, incluidos la restauración de la pigmentación, los mecanismos de cicatrización y el análisis de rentabilidad de los aloinjertos placentarios.
MIMEDX (NASDAQ:MDXG)는 2025년 9월 3일~6일 라스베이거스에서 열리는 Symposium on Advanced Wound Care(SAWC) Fall 회의에 참가한다고 발표했습니다. 회사는 2025년 9월 4일에 "Change is Inevitable: Mastering the Art of Wound Healing in an Evolving Landscape"라는 제목의 후원 런치 심포지엄을 개최합니다.
MIMEDX는 부스 511에서 첨단 상처 치료 제품군을 선보이며 색소 회복, 상처 치유 메커니즘, 태반 동종이식편의 비용효과 분석 등 태아막 조직 적용의 다양한 측면을 다룬 여섯 편의 임상·과학 포스터를 발표합니다.
MIMEDX (NASDAQ:MDXG) a annoncé sa participation au Symposium on Advanced Wound Care (SAWC) Fall, qui se tiendra du 3 au 6 septembre 2025 à Las Vegas. La société organisera un déjeuner-symposium sponsorisé intitulé « Change is Inevitable: Mastering the Art of Wound Healing in an Evolving Landscape » le 4 septembre 2025.
MIMEDX présentera son portefeuille de soins avancés des plaies au stand 511 et exposera six posters cliniques et scientifiques portant sur divers aspects des applications de tissu amniotique, notamment la restauration de la pigmentation, les mécanismes de cicatrisation et l'analyse de coût-efficacité des allogreffes placentaires.
MIMEDX (NASDAQ:MDXG) hat seine Teilnahme am Symposium on Advanced Wound Care (SAWC) Fall vom 3. bis 6. September 2025 in Las Vegas angekündigt. Das Unternehmen veranstaltet am 4. September 2025 ein gesponsertes Lunch-Symposium mit dem Titel "Change is Inevitable: Mastering the Art of Wound Healing in an Evolving Landscape".
MIMEDX präsentiert sein Portfolio zur fortschrittlichen Wundversorgung an Stand 511 und stellt sechs klinische und wissenschaftliche Poster vor, die verschiedene Aspekte der Anwendung von Amniongewebe beleuchten, darunter Pigmentwiederherstellung, Wundheilungsmechanismen und Kosten-Nutzen-Analysen von Plazenta-Allotransplantaten.
- None.
- None.
To Present Six Posters Featuring the Company’s Latest Product Innovations
MARIETTA, Ga., Sept. 03, 2025 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”) today announced its schedule for the Symposium on Advanced Wound Care (SAWC) Fall meeting taking place September 3-6 in Las Vegas, NV. SAWC remains a premier event for clinicians and industry professionals to explore the latest clinical evidence and innovations in advanced wound care. The Company will showcase its leading advanced wound care portfolio in the exhibit hall at booth 511.
Sponsored Lunch Symposium
Title: Change is Inevitable: Mastering the Art of Wound Healing in an Evolving Landscape
Date: Thursday, September 4, 2025
Time: 11:40 – 1:10 p.m. PDT
Faculty: Paul Kim, DPM, MS, FACFAS; Nicolas Mouawad, MD, MPH, MBA, DFSVS, FRCS, FACS, RPVI; Scott Boynton, DPM, FACFAS
Description: Wound care is constantly evolving, and clinicians must adapt to an ever-changing landscape of patient complexities and clinical challenges. In this dynamic symposium, Drs. Paul Kim, Nicolas Mouawad, and Scott Boynton will discuss advanced treatment approaches that support clinicians in optimizing wound healing across diverse patient populations and present challenging real-world cases.
Accepted Poster Presentations
The Company is pleased to announce that six clinical and scientific posters have been accepted and will be on display in the poster hall.
- Therapeutic Potential of Amniotic Tissue in Promoting Pigment Restoration During Wound Healing
- Bovine Extracellular Matrix Particulate Modulates Fibroblast Cellular Activities Supportive of Wound Management
- Characterization of PURION® Processed Dual Layer Chorion Allograft
- Amniotic Membrane Allografts promote re-epithelialization in vitro via cJUN Mediated Mechanism
- Adjunctive Dehydrated Human Amnion Chorion Membrane Usage for Pressure Injuries in the Post-Acute Care Setting
- Reconstruction Following Mohs Surgery with a Placental Allograft: A Cost-Effectiveness Analysis
About MIMEDX
MIMEDX is a pioneer and leader focused on helping humans heal. With more than a decade of helping clinicians manage chronic and other hard-to-heal wounds, MIMEDX is dedicated to providing a leading portfolio of products for applications in the wound care, burn, and surgical sectors of healthcare. The Company’s vision is to be the leading global provider of healing solutions through relentless innovation to restore quality of life. For additional information, please visit www.mimedx.com.
Contact:
Matt Notarianni
Investor Relations
470-304-7291
mnotarianni@mimedx.com
